The launch builds on the firm’s long-term investment in digital infrastructure, including early adoption of a fully integrated client platform offering real-time access to private market investments ...

– NeoGenomics wins summary judgment in patent infringement lawsuit against Natera; Court rules Natera’s patents are invalid for claiming ineligible subject matter – NeoGenomics remains free to make, ...

Genomics and Harvard University have sued Element Biosciences, alleging that Element’s AVITI24™ multiomics platform, Teton ...

PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Thursday reported a loss of $13.5 million in its first quarter.

A federal judge canceled next week’s jury trial over claims Curio Bioscience Inc.’s tissue-mapping kits infringe five spatial ...

Forbes contributors publish independent expert analyses and insights. Anisha Sircar is a journalist covering tech, finance and society. UKRAINE - 2021/06/17: In this photo illustration, 23andMe logo ...

PLEASANTON, Calif., April 15, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the first quarter ended ...

As reported by WSB Radio, those samples then became the basis for high-priced genetic tests that were pitched as cancer or ...

The genomics community’s long wait for 10x Genomics’ highly anticipated news is finally over. On Saturday night, at the Hard Rock Café Hotel in San Diego—across the street from the American ...

Hematopoietic Stem-Cell Transplantation: Exploring the Latest Advances and Gaps in Disparities, Psychosocial and Symptom Management Interventions, and Chronic Graft-Versus-Host Disease Care Although ...

Global DNA Diagnostics Market Growth is Fueled by Rising Prevalence of Genetic Disorders, Increasing Adoption of Precision Medicine, and Rapid Technological Advancements in Molecular ...

Strategic Buy Lights Up This Biotech Stock: Time to Invest? 10x Genomics (NASDAQ:TXG) reported a first-quarter revenue ...